ADXN Addex Therapeutics
- 10.9600
- +0.2600+2.43%
Addex Therapeutics所有資訊
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(5.1%),New Enterprise Associates 15, L.P.(5.1%)等
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(6.4%),New Enterprise Associates 15, L.P.(6.4%)等
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Timothy Mark Dyer(14.16%)
Addex Therapeutics | D：發行公告
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(8.5%),New Enterprise Associates 15, L.P.(8.5%)等
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Timothy Mark Dyer(11.09%)
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Timothy Mark Dyer(12.18%)
Addex Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Addex Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Caxton Corporation(0.9%),CDK Associates, L.L.C.(0.9%)等
Addex Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Armistice Capital, LLC(4.97%),Steven Boyd(4.97%)
Addex Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(0.0 %),GOLDMAN SACHS & CO. LLC(0.0 %)
Addex Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-New Leaf Biopharma Opportunities I, L.P.(3.0%),New Leaf BPO Associates I, L.P.(3.0%)等
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(9.7%),New Enterprise Associates 15, L.P.(9.7%)等
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Timothy Mark Dyer(13.54%)
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Timothy Mark Dyer(20.01%)
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(15.1%),New Enterprise Associates 15, L.P.(15.1%)等
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Timothy Mark Dyer(8.40%)
Addex Therapeutics | D：發行公告
Addex Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-New Leaf Biopharma Opportunities I, L.P.(6.2%),New Leaf BPO Associates I, L.P.(6.2%)等
分析
目標價預測
暫無數據
暫無數據